A 45-year-old woman with asthma uses salbutamol via metered-dose inhaler (MDI) most days for breathlessness and nocturnal symptoms twice per week. She is not on preventer therapy. Spirometry confirms reversible obstruction. According to Australian asthma guidelines, what is the most appropriate next step?